As for Chia Tai Feng Hai, the company is owned by parent company Sino Biopharmaceutical, a large Chinese pharma based in Hong ...

Scientists at the Joint BioEnergy Institute (JBEI) have developed two methods to accelerate the ...

TEL AVIV and REHOVOT, Israel, July 17, 2024 /PRNewswire/ -- ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, and Lavie Bio Ltd., a leading ag-biologicals company and ...

Converge Bio, the AI platform for accelerated drug discovery and development, announced today $25 million in Series A funding, bringing its total raised to $30 million. The round was led by Bessemer ...

This expansion is in addition to the previously announced Microsoft (MSFT) for Startups program. PredicTcell, Tevogen Bio’s proprietary technology, is designed for predictive, precision T cell target ...

AI drug discovery startup Converge Bio raised $25 million in a Series A led by Bessemer Venture Partners, with additional backing from executives at Meta, OpenAI, and Wiz.

As we approach the end of 2024, First Opinion is publishing a series of essays on the state of AI in medicine and biopharma. There’s more to life than protein folding. You’d be forgiven for believing ...

"CGIE™ is being built as future-facing infrastructure rather than a point solution," said Yusuf Henriques, Founder and CEO of IndyGeneUS Bio. "Our objective is to establish the AI×Bio Factory —the ...

The plastic needles on your next artificial Christmas tree may actually be plant-based — although not as plant-based as a real tree, of course. Balsam Brands, the company that makes the Balsam Fir ...

Superhydrophobicity, superomniphobicity, underwater superoleophobicity, and slippery property are the basis for deriving various functional materials and interfaces for energy, healthcare, and ...